What question did this study set out to answer?

The aim is to explore how mutations in KCNJ10 affect hypokalemia through the involvement of the mTOR pathway in the distal convoluted tubule.

March 27, 2026Open Access

WCN26-2869 HYPOKALEMIA IN EAST/SESAME SYNDROME: POTENTIAL ROLE OF mTOR PATHWAY

Puntos clave

The aim is to explore how mutations in KCNJ10 affect hypokalemia through the involvement of the mTOR pathway in the distal convoluted tubule.
Utilized genetic analysis to confirm mutations in KCNJ10.
Investigated Kir4.1 deletion effects in distal convoluted tubule cells.
Examined ENaC activity regulation by mTOR signaling.
Kir4.1 deletion was linked to increased ENaC activity.
mTOR-dependent mechanisms were suggested as mediators of this increase.
Findings indicate a direct role of the mTOR pathway in hypokalemia associated with EAST/SeSAME syndrome.

Resumen

Loss-of-function mutations in KCNJ10, encoding Kir4.1, cause EAST/SeSAME syndrome, with renal salt-wasting tubulopathy and hypokalemia. We hypothesized that Kir4.1 deletion specifically in the distal convoluted tubule (DCT) stimulates epithelial sodium channel (ENaC) activity via the mammalian target of rapamycin (mTOR)-dependent mechanisms, contributing to hypokalemia.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo